Dave CV, Patorno E, Franklin JM, Huybrechts KF, Sarpatwari A, Kesselheim AS, Bateman BT - Journal of General Internal Medicine
Following implementation of 7-day opioid duration limits for opioid-naïve patients in Massachusetts, Connecticut, and New York in 2016, pooled analysis showed a decreased probability of initiating a >7-day prescription and shorter opioid duration, though without an immediate reduction in total morphine equivalent dose. Between-state heterogeneity was notable, with Massachusetts and Connecticut showing immediate declines in opioid duration while New York’s effect was delayed, suggesting variable implementation and enforcement of these laws across states.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Daval CJR, Kesselheim AS - STAT
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine